Who to call at Arvinas, and when
Fundz watches for the moments Arvinas starts buying, and tells you who to reach.
- An alert the day Arvinas raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Arvinas, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Arvinas. With Fundz connected, it knows.
Contract Type
licensing
Description
On May 11, 2026, Arvinas, Inc. entered into a license agreement with Rigel Pharmaceuticals, Inc. This agreement grants Rigel exclusive global development, manufacturing, and commercialization rights for VEPPANU™. The collaboration aims to leverage both companies' strengths in bringing innovative treatments to market.
Quick answer
Arvinas Enters License Agreement with Rigel Pharmaceuticals (May 12, 2026). Arvinas is based in New Haven, Connecticut, United States.
- What agreement did Arvinas announce on May 12, 2026?
- On May 11, 2026, Arvinas, Inc. entered into a license agreement with Rigel Pharmaceuticals, Inc. This agreement grants Rigel exclusive global development, manufacturing, and commercialization rights for VEPPANU™. The collaboration aims to leverage both companies' strengths in bringing innovative treatments to market.
- What does Arvinas do?
- Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of...
- Where is Arvinas based?
- Arvinas is based in New Haven, Connecticut, United States.
Source: Fundz verified event record.
Related People
Arvinas signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.